Update date
30 Jun 2019
Sources and sharing
RCEL - AVITA Medical, Inc. Current Assets
- Context
- Latest reported period: Q2 2019
- Latest reported value
- A$34,578,882
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Tracking and update notes
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Jun 2019
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q2 2019.
- Latest reported value on this page: A$34,578,882.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Current Assets
Latest reported current assets: A$34,578,882. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q2 2019
SEC-backed company facts were refreshed from filings filed on 06 Aug 2026.
Benchmark Context
How Current Assets compares with peers
AVITA Medical, Inc. sits in the upper half of the current current assets sample.
Compared with
Compared with 3 companies reporting current assets in AUD. This keeps the comparison on the same metric and unit family.
Why this is notable
That is about 1.7x the current visible midpoint. Current Assets is up about 55% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2019 to 30 Jun 2025.
- Nearby companies in this sample: Nova Minerals Corp and Neuphoria Therapeutics Inc..
- Current sample position: rank #1 of 3 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Financial Metric Page
AVITA Medical, Inc.: Current Assets
Latest period: Q2 2019. Period end: 30 Jun 2019. Units: AUD. Frequency: quarterly.
Current Assets is reported in company XBRL facts filed with the SEC.
Metric snapshot
- Latest value
- A$34,578,882
- Coverage range
- 30 Jun 2018 - 30 Jun 2019
- Fact rows
- 2
What this metric tells you
- Shows reported current assets over 30 Jun 2018 - 30 Jun 2019.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 2 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Current Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
AVITA Medical, Inc. appears at rank #1 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | AVITA Medical, Inc. (rcel) | A$34,578,882 | Instant - 30 Jun 2019 | Open AVITA Medical, Inc. Current Assets |
| 2 | Neuphoria Therapeutics Inc. (neup) | A$20,095,746 | Instant - 30 Jun 2023 | Open Neuphoria Therapeutics Inc. Current Assets |
| 3 | Nova Minerals Corp (nva) | A$9,374,817 | Instant - 30 Jun 2025 | Open Nova Minerals Corp Current Assets |
Metric Details
- Metric
- Current Assets (CurrentAssets)
- Frequency coverage
-
quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- ifrs-full
- Units tracked
- AUD
- History range
-
30 Jun 2018 - 30 Jun 2019
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
2
Source: SEC company facts API
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Current Assets, Quarterly (AUD)
Current Assets, YoY Quarterly Change (%)
AVITA Medical, Inc. Quarterly Current Assets (AUD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2019 | A$34,578,882 | +A$12,304,451 | +55% | 30 Jun 2019 | 20-F/A | 19 Nov 2019 | 2019 | FY |
| Q2 2018 | A$22,274,431 | 30 Jun 2018 | 20-F/A | 19 Nov 2019 | 2019 | FY |
* marks a reported value that did not pass the local value check.